Leishmaniasis, Visceral clinical trials

The registry lists 68 studies for Leishmaniasis, Visceral across more than 10 countries. 7 are recruiting or about to start. 62 of them are mainly about Leishmaniasis, Visceral (how this is decided). Per ClinicalTrials.gov, last updated 2026-10-29.

Get an email when these change. Save the Leishmaniasis, Visceral studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies

See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed: 48
Recruiting: 7
Terminated: 7
Status unknown: 4
Active, not recruiting: 1
Withdrawn: 1

Phase

Phase 3: 13
Phase 2: 13
Phase 1: 7
Phase 4: 5
Early Phase 1: 2

Where

India: 17
Ethiopia: 14
Bangladesh: 10
Kenya: 8
Sudan: 8
Brazil: 5

Who runs them

Drugs for Neglected Diseases (13) · Banaras Hindu University (8) · International Centre for Diarrhoeal Disease Research, Bangladesh (7) · Institute of Tropical Medicine, Belgium (6) · Foundation for Innovative New Diagnostics, Switzerland (4) · Access to Advanced Health Institute (AAHI) (3) · PATH (3) · University of Brasilia (2)

What is being tested here

Drugs under test in Leishmaniasis, Visceral studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

Drug	Phase 3	All
Amphotericin B	5	12
Miltefosine	5	10
Liposomal amphotericin B	5	10
Paromomycin	6	8
LXE408	0	1
Pentamidine	1	1
Sitamaquine	0	1
TLR4 Agonist G100	0	1
Albendazole	0	1
Iron	0	1

Coming up

0phase 3 studies under way

3studies finish main data collection within a year

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

All 3

Dec 2026Ex Vivo Immunogenicity Screening of Vaccine Candidate Antigen Combinations in Ethiopian Patients With Leishmaniasis · Institute of Tropical Medicine, Belgium
Dec 2026Clinical Prognostic Score to Predict Relapse in VL · Institute of Tropical Medicine, Belgium
Apr 2027Recurrent Visceral Leishmaniasis in HIV Co-Infection · Institute of Tropical Medicine, Belgium

Who these studies take

Of the 7 Leishmaniasis, Visceral studies recruiting now, 2 (29%) set no upper age limit and 3 (43%) stop at 75 or younger. 4 (57%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 1 (14%) take healthy volunteers.

Recruiting studies that take each age, of 7
Age	Women	Men
10	3 (43%)	3 (43%)
18	6 (86%)	6 (86%)
30	6 (86%)	6 (86%)
40	6 (86%)	6 (86%)
50	6 (86%)	6 (86%)
65	6 (86%)	6 (86%)
75	5 (71%)	5 (71%)
85	4 (57%)	4 (57%)

Across all 68 studies, recruiting or not: 66% stop at 75 or younger and 63% at 65; 72% take children; 0% are for women only and 0% for men only; 19% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

Studies

Recruiting first, then most recently updated. Showing 50 of 68. Browse all 68 → or search them.